Drugs for HER-2-positive breast cancer
Growth factor receptors have long been known to drive malignant transformation and cancer progression. The epidermal growth factor receptor (EGFR, ErbB, HER) system is likely the best described membrane receptor tyrosine kinase family in malignant tumors. With implementation of the growth-inhibitory...
| Опубликовано в:: | Springer eBooks. |
|---|---|
| Соавтор: | |
| Другие авторы: | , , , |
| Формат: | Electronic Resource |
| Язык: | English |
| Опубликовано: |
Basel
Springer Basel
c2011.
|
| Предметы: | |
| Online-ссылка: | Available for University of the Philippines Diliman via SpringerLink. Click here to access |


